双胚胎移植后宫内血肿患者减胎的妊娠结局
本研究分析双胚胎移植后行减胎患者的临床资料,按年龄、周期类型和受精方式1:4匹配,纳入34例宫内血肿患者与136例无血肿患者。宫内血肿患者早期胎死(20.6% vs 7.4%,P=0.048)、先兆流产(48.1% vs 10.3%,P<0.001)及产后出血(14.8% vs 4.0%,P=0.043)发生率均高于无血肿患者;调整混杂因素后,宫内血肿是早期胎死(aOR 3.34,95%CI 1.14-9.77)和先兆流产(aOR 8.61,95%CI 3.28-22.61)的独立危险因素。作者认为宫内血肿患者减胎时应谨慎。
要点
- 双胚胎移植后减胎患者中,宫内血肿者早期胎死(20.6% vs 7.4%)和先兆流产(48.1% vs 10.3%)发生率更高。
- 宫内血肿是早期胎死(aOR 3.34,95%CI 1.14-9.77)和先兆流产(aOR 8.61,95%CI 3.28-22.61)的独立危险因素。
- 减胎后发生流产的宫内血肿妊娠,其血肿体积更大且诊断时间更早(均P<0.03)。
核心结论
- 双胚胎移植后宫内血肿患者减胎时胎死风险相对较高,应谨慎进行。
- 应特别关注有早期先兆流产迹象和不可避免胎死迹象的宫内血肿患者。
研究设计与样本
- 分析双胚胎移植后行减胎女性的临床信息和妊娠结局。
- 排除患有其他系统疾病、异位妊娠或宫内外同时妊娠、单绒毛膜双胎妊娠及数据不完整的患者。
- 按宫内血肿相关特征对宫内血肿妊娠进行分层。
- 主要结局为胎死(<24周)发生率,其他不良妊娠结局为次要结局。
- 基于年龄、周期类型和受精方式1:4匹配,纳入34例宫内血肿患者和136例无宫内血肿患者。
主要发现
- 宫内血肿患者早期胎死发生率为20.6%,无宫内血肿患者为7.4%(P=0.048)。
- 宫内血肿患者先兆流产发生率为48.1%,无宫内血肿患者为10.3%(P<0.001)。
- 宫内血肿患者产后出血发生率为14.8%,无宫内血肿患者为4.0%(P=0.043)。
- 调整潜在混杂因素后,宫内血肿是早期胎死的独立危险因素(aOR 3.34,95%CI 1.14-9.77)。
- 调整潜在混杂因素后,宫内血肿是先兆流产的独立危险因素(aOR 8.61,95%CI 3.28-22.61)。
临床怎么用
- 作者认为,双胚胎移植后宫内血肿患者减胎时胎死风险相对较高,应谨慎进行。
- 作者认为,应特别关注有早期先兆流产迹象和不可避免胎死迹象的宫内血肿患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is there an association between intrauterine haematoma (IUH) and pregnancy outcomes in patients who undergo fetal reduction after double embryo transfer (DET), and if so, what is the relationship between IUH-related characteristics and pregnancy outcomes? DESIGN: Clinical information and pregnancy outcomes of women who underwent fetal reduction after DET were analysed. Patients with other systematic diseases, ectopic pregnancy or heterotopic pregnancy, monochorionic twin pregnancies and incomplete data were excluded. Stratification of IUH pregnancies was undertaken based on IUH-related characteristics. The main outcome was incidence of fetal demise (<24 weeks), with other adverse pregnancy outcomes considered as secondary outcomes. RESULTS: Thirty-four IUH patients and 136 non-IUH patients who underwent fetal reduction after DET were included based on a 1:4 match for age, cycle type and fertilization method. IUH patients had a higher incidence of early fetal demise (20.6% versus 7.4%, P = 0.048), threatened abortion (48.1% versus 10.3%, P<0.001) and postpartum haemorrhage (PPH; 14.8% versus 4.0%, P = 0.043) compared with non-IUH patients. IUH was an independent risk factor for early fetal demise [adjusted OR (aOR) 3.34, 95% CI 1.14-9.77] and threatened abortion (aOR 8.61, 95% CI 3.28-22.61) after adjusting for potential confounders. IUH pregnancies undergoing fetal reduction that resulted in miscarriage had larger IUH volumes and earlier diagnosis (both P < 0.03). However, IUH characteristics (i.e. volume, changing pattern, presence or absence of cardiac activity) were not associated with threatened abortion or PPH. CONCLUSIONS: Fetal reduction should be performed with caution in IUH pregnancies after DET as the risk of fetal demise is relatively high. Particular attention should be given to IUH patients with early signs of threatened abortion and inevitable fetal demise.
引用
- Ge Y, Lai S, Shi J, et al. Pregnancy outcomes of fetal reduction in patients with intrauterine haematoma following double embryo transfer. Reprod Biomed Online. 2023. PMID: 38215685. doi:10.1016/j.rbmo.2023.103644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。